Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1233

1.

Long-term Remission by Brentuximab Vedotin for Non-mediastinal Gray Zone Lymphoma Refractory to Autologous Stem Cell Transplantation.

Ebisawa K, Masamoto Y, Koya J, Shimura A, Shinozaki-Ushiku A, Toyama K, Nakazaki K, Kurokawa M.

Clin Lymphoma Myeloma Leuk. 2019 Aug 30. pii: S2152-2650(19)31387-4. doi: 10.1016/j.clml.2019.08.017. [Epub ahead of print] No abstract available.

PMID:
31551171
2.

Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.

Shinohara A, Oshima K, Fuji S, Umeda K, Kako S, Kurokawa M, Tsukada N, Kasai M, Kondo T, Hashii Y, Nakamae H, Ikegame K, Kosaka Y, Shimada A, Nawa Y, Makoto Y, Yoshiko A, Fukuda T, Tanaka J, Ogata M.

Biol Blood Marrow Transplant. 2019 Sep 5. pii: S1083-8791(19)30561-0. doi: 10.1016/j.bbmt.2019.08.021. [Epub ahead of print]

PMID:
31494230
3.

Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.

Ito Y, Toyama K, Honda A, Nakazaki K, Arai S, Kurokawa M.

J Infect Chemother. 2019 Aug 14. pii: S1341-321X(19)30227-2. doi: 10.1016/j.jiac.2019.07.016. [Epub ahead of print]

PMID:
31421950
4.

Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Miyazaki Y, Kurokawa M, Arai S, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Int J Hematol. 2019 Jul 29. doi: 10.1007/s12185-019-02710-1. [Epub ahead of print]

PMID:
31359362
5.

Recombinant human soluble thrombomodulin ameliorates acetaminophen-induced liver toxicity in mice.

Kuwano A, Kohjima M, Suzuki H, Yamasaki A, Ohashi T, Imoto K, Kurokawa M, Morita Y, Kato M, Ogawa Y.

Exp Ther Med. 2019 Aug;18(2):1323-1330. doi: 10.3892/etm.2019.7665. Epub 2019 Jun 11.

6.

Effect of inactivated Streptococcus pneumoniae as non-pathogenic particles on the severity of pneumonia caused by respiratory syncytial virus infection in mice.

Miyauchi A, Watanabe W, Akashi T, Hashiguchi S, Yoshida H, Sugita C, Kurokawa M.

Toxicol Rep. 2019 May 31;6:514-520. doi: 10.1016/j.toxrep.2019.05.004. eCollection 2019.

7.

Estimation of the potential of landfill mining and exploration of metal-enriched zones.

Kamura K, Omori M, Kurokawa M, Tanaka H.

Waste Manag. 2019 Jun 15;93:122-129. doi: 10.1016/j.wasman.2019.04.050. Epub 2019 May 24.

PMID:
31235048
8.

Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice.

Tsuhako R, Yoshida H, Sugita C, Kurokawa M.

J Nat Med. 2019 Jun 19. doi: 10.1007/s11418-019-01332-5. [Epub ahead of print]

PMID:
31218550
9.

Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling.

Kaji T, Arito M, Tsutiya A, Sase T, Onodera H, Sato T, Omoteyama K, Sato M, Suematsu N, Kurokawa MS, Tanaka Y, Kato T.

Brain Res. 2019 Sep 15;1719:140-147. doi: 10.1016/j.brainres.2019.05.034. Epub 2019 May 27.

PMID:
31145904
10.

Significance of biopsy with ERCP for diagnosis of bile duct invasion of DLBCL.

Ito Y, Miyauchi M, Nakamura T, Takahara N, Nakai Y, Taoka K, Toyama K, Shinozaki-Ushiku A, Koike K, Kurokawa M.

Int J Hematol. 2019 Sep;110(3):381-384. doi: 10.1007/s12185-019-02661-7. Epub 2019 May 15.

PMID:
31093933
11.

Arteritis after administration of granulocyte colony-stimulating factor: a case series.

Sasaki K, Miyauchi M, Ogura M, Shimura-Nukina A, Toyama K, Nakazaki K, Watadani T, Abe O, Kurokawa M.

Int J Hematol. 2019 Sep;110(3):370-374. doi: 10.1007/s12185-019-02662-6. Epub 2019 May 14.

PMID:
31090035
12.

Hlf marks the developmental pathway for hematopoietic stem cells but not for erythro-myeloid progenitors.

Yokomizo T, Watanabe N, Umemoto T, Matsuo J, Harai R, Kihara Y, Nakamura E, Tada N, Sato T, Takaku T, Shimono A, Takizawa H, Nakagata N, Mori S, Kurokawa M, Tenen DG, Osato M, Suda T, Komatsu N.

J Exp Med. 2019 Jul 1;216(7):1599-1614. doi: 10.1084/jem.20181399. Epub 2019 May 10.

PMID:
31076455
13.

Efficiency of fluorescent cholangiography during laparoscopic cholecystectomy for subvesical bile ducts: A case report.

Kitamura H, Tsuji T, Yamamoto D, Takahashi T, Kadoya S, Kurokawa M, Bando H.

Int J Surg Case Rep. 2019;57:194-196. doi: 10.1016/j.ijscr.2019.03.042. Epub 2019 Mar 30.

14.

Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia.

Mori T, Onishi Y, Ozawa Y, Kato C, Kai T, Kanda Y, Kurokawa M, Tanaka M, Ashida T, Sawayama Y, Fukuda T, Ichinohe T, Atsuta Y, Yamazaki H.

Int J Hematol. 2019 Jun;109(6):711-717. doi: 10.1007/s12185-019-02644-8. Epub 2019 Apr 8.

PMID:
30963471
15.

A proteomic analysis of serum-derived exosomes in rheumatoid arthritis.

Tsuno H, Arito M, Suematsu N, Sato T, Hashimoto A, Matsui T, Omoteyama K, Sato M, Okamoto K, Tohma S, Kurokawa MS, Kato T.

BMC Rheumatol. 2018 Nov 27;2:35. doi: 10.1186/s41927-018-0041-8. eCollection 2018.

16.

TUBB1 dysfunction in inherited thrombocytopenia causes genome instability.

Matsumura T, Nakamura-Ishizu A, Takaoka K, Maki H, Muddineni SSNA, Wang CQ, Suzushima H, Kawakita M, Asou N, Matsuoka M, Kurokawa M, Osato M, Suda T.

Br J Haematol. 2019 Jun;185(5):888-902. doi: 10.1111/bjh.15835. Epub 2019 Mar 10.

PMID:
30854628
17.

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.

Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators.

Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14.

PMID:
30762219
18.

Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.

Ebisawa K, Masamoto Y, Tokushige J, Nishi H, Honda K, Hinata M, Toyama K, Nangaku M, Kurokawa M.

Ann Hematol. 2019 Aug;98(8):1995-1997. doi: 10.1007/s00277-019-03616-y. Epub 2019 Feb 13. No abstract available.

PMID:
30761408
19.

A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination.

Takaoka K, Kawazu M, Koya J, Yoshimi A, Masamoto Y, Maki H, Toya T, Kobayashi T, Nannya Y, Arai S, Ueno T, Ueno H, Suzuki K, Harada H, Manabe A, Hayashi Y, Mano H, Kurokawa M.

Leukemia. 2019 Jul;33(7):1773-1782. doi: 10.1038/s41375-019-0385-0. Epub 2019 Jan 29.

PMID:
30696947
20.

Psychometric properties of a Japanese version of Composite Scale of Morningness.

Kato Y, Urbán R, Saito S, Yoshida K, Kurokawa M, Rigó A.

Heliyon. 2019 Jan 4;5(1):e01092. doi: 10.1016/j.heliyon.2018.e01092. eCollection 2019 Jan.

21.

Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence.

Uni M, Kurokawa M.

Oncotarget. 2018 Dec 7;9(96):36828-36829. doi: 10.18632/oncotarget.26423. eCollection 2018 Dec 7. No abstract available.

22.

Reinforcement of the Triple D score with simple addition of the intrarenal location for the prediction of the stone-free rate after shockwave lithotripsy for renal stones 10-20 mm in diameter.

Ichiyanagi O, Fukuhara H, Kurokawa M, Izumi T, Suzuki H, Naito S, Nishida H, Kato T, Tsuchiya N.

Int Urol Nephrol. 2019 Feb;51(2):239-245. doi: 10.1007/s11255-018-02066-1. Epub 2019 Jan 2.

PMID:
30604235
23.

Redox-tuning of oxidizing disulfide oxidoreductase generates a potent disulfide isomerase.

Sutoh S, Uemura Y, Yamaguchi Y, Kiyotou A, Sugihara R, Nagayasu M, Kurokawa M, Ito K, Tsunekawa N, Nemoto M, Inagaki K, Tamura T.

Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):194-201. doi: 10.1016/j.bbapap.2018.12.005. Epub 2018 Dec 18.

PMID:
30576741
24.

Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.

Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

Clin Gastroenterol Hepatol. 2019 May;17(6):1192-1200. doi: 10.1016/j.cgh.2018.11.047. Epub 2018 Nov 28.

25.

Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma.

Kurokawa M, Koya T, Takeuchi H, Hayashi M, Sakagami T, Ishioka K, Gon Y, Hasegawa T, Kikuchi T.

J Asthma. 2018 Nov 29:1-8. doi: 10.1080/02770903.2018.1541357. [Epub ahead of print]

PMID:
30489179
26.

Antiviral activity of hypothiocyanite produced by lactoperoxidase against influenza A and B viruses and mode of its antiviral action.

Sugita C, Shin K, Wakabayashi H, Tsuhako R, Yoshida H, Watanabe W, Kurokawa M.

Acta Virol. 2018;62(4):401-408. doi: 10.4149/av_2018_408.

PMID:
30472870
27.

Verification of the effect of the axon fluid as a highly dielectric medium in the high-speed conduction of action potentials using a novel axon equivalent circuit.

Tsubo T, Kurokawa M.

Biophys Physicobiol. 2018 Oct 25;15:214-228. doi: 10.2142/biophysico.15.0_214. eCollection 2018.

28.

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.

Dumas PY, Mansier O, Prouzet-Mauleon V, Koya J, Villacreces A, Brunet de la Grange P, Luque Paz D, Bidet A, Pasquet JM, Praloran V, Salin F, Kurokawa M, Mahon FX, Cardinaud B, Lippert E.

BMC Cancer. 2018 Nov 12;18(1):1098. doi: 10.1186/s12885-018-4993-2.

29.

Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.

Senda N, Miyagaki T, Oka T, Itoigawa A, Kikuchi K, Kobayashi T, Nakamura F, Kurokawa M, Sugaya M, Sato S.

J Dermatol. 2019 May;46(5):e161-e163. doi: 10.1111/1346-8138.14701. Epub 2018 Oct 31. No abstract available.

PMID:
30379350
30.

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate.

Taoka K, Arai S, Kataoka K, Hosoi M, Miyauchi M, Yamazaki S, Honda A, Aixinjueluo W, Kobayashi T, Kumano K, Yoshimi A, Otsu M, Niwa A, Nakahata T, Nakauchi H, Kurokawa M.

Sci Rep. 2018 Oct 26;8(1):15855. doi: 10.1038/s41598-018-34193-1.

31.

Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.

Harashima S, Yoneda R, Horie T, Fujioka Y, Nakamura F, Kurokawa M, Yoshiuchi K.

Bone Marrow Transplant. 2019 Jul;54(7):1013-1021. doi: 10.1038/s41409-018-0371-6. Epub 2018 Oct 23.

PMID:
30353064
32.

Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.

Yoh T, Hatano E, Kasai Y, Fuji H, Nishi K, Toriguchi K, Sueoka H, Ohno M, Seo S, Iwaisako K, Taura K, Yamaguchi R, Kurokawa M, Fujimoto J, Kimura T, Uemoto S, Nishi E.

Clin Cancer Res. 2019 Jan 15;25(2):619-628. doi: 10.1158/1078-0432.CCR-18-0124. Epub 2018 Oct 23.

PMID:
30352908
33.

Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.

Ichiyanagi O, Naito S, Ito H, Kabasawa T, Narisawa T, Kanno H, Kurota Y, Kurokawa M, Fukuhara H, Sakurai T, Nishida H, Kato T, Yamakawa M, Tsuchiya N.

Clin Genitourin Cancer. 2018 Oct;16(5):e1029-e1058. doi: 10.1016/j.clgc.2018.06.002. Epub 2018 Jun 8.

34.

A Pilot Study for the Detection of Cyclic Prolyl-Hydroxyproline (Pro-Hyp) in Human Blood after Ingestion of Collagen Hydrolysate.

Shigemura Y, Iwasaki Y, Tateno M, Suzuki A, Kurokawa M, Sato Y, Sato K.

Nutrients. 2018 Sep 22;10(10). pii: E1356. doi: 10.3390/nu10101356.

35.

Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold.

Shin K, Wakabayashi H, Sugita C, Yoshida H, Sato K, Sonoda T, Yamauchi K, Abe F, Kurokawa M.

Int J Health Sci (Qassim). 2018 Sep-Oct;12(5):44-50.

36.

A decay effect of the growth rate associated with genome reduction in Escherichia coli.

Tsuchiya K, Cao YY, Kurokawa M, Ashino K, Yomo T, Ying BW.

BMC Microbiol. 2018 Sep 3;18(1):101. doi: 10.1186/s12866-018-1242-4.

37.

Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients.

Aoki T, Yamada A, Takahashi M, Niikura R, Toyama K, Ushiku T, Kurokawa M, Momose T, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2019 Apr;34(4):693-699. doi: 10.1111/jgh.14452. Epub 2018 Sep 19.

PMID:
30151937
38.

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis.

Matsuda K, Koya J, Arai S, Nakazaki K, Nakamura F, Kurokawa M.

Intern Med. 2019 Feb 1;58(3):355-360. doi: 10.2169/internalmedicine.1372-18. Epub 2018 Aug 24.

39.

Usefulness of presepsin for early detection of infections in patients with hematologic disorders.

Ebisawa K, Koya J, Nakazaki K, Arai S, Nakamura F, Kurokawa M.

Clin Chim Acta. 2018 Nov;486:374-380. doi: 10.1016/j.cca.2018.08.032. Epub 2018 Aug 23. No abstract available.

PMID:
30144441
40.

Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease.

Matsuda K, Honda A, Arai S, Maki H, Nakazaki K, Kurokawa M.

Bone Marrow Transplant. 2019 Feb;54(2):316-319. doi: 10.1038/s41409-018-0274-6. Epub 2018 Aug 14. No abstract available.

PMID:
30108328
41.

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.

Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

J Gastroenterol. 2019 Feb;54(2):171-181. doi: 10.1007/s00535-018-1499-2. Epub 2018 Aug 13.

42.

Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.

Chiba A, Toya T, Mizuno H, Tokushige J, Nakamura F, Nakazaki K, Kurokawa M.

Int J Hematol. 2018 Dec;108(6):640-646. doi: 10.1007/s12185-018-2511-6. Epub 2018 Aug 4. Review.

PMID:
30078165
43.

Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Nov;103(11):1815-1824. doi: 10.3324/haematol.2018.190728. Epub 2018 Jul 5.

44.

Gallbladder Metastasis from Renal Cell Carcinoma.

Kitamura H, Kurokawa M, Inaki N, Bando H.

Indian J Surg. 2018 Jun;80(3):278-280. doi: 10.1007/s12262-017-1705-0. Epub 2017 Nov 27.

45.

Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification.

Uni M, Masamoto Y, Sato T, Kamikubo Y, Arai S, Hara E, Kurokawa M.

Leukemia. 2019 Jan;33(1):191-204. doi: 10.1038/s41375-018-0198-6. Epub 2018 Jul 2.

PMID:
29967380
46.

Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study.

Matsuda A, Kawabata H, Tohyama K, Maeda T, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Usuki K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Ohta A, Miyazaki Y, Nakao S, Ozawa K, Arai S, Kurokawa M, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Leuk Res. 2018 Nov;74:137-143. doi: 10.1016/j.leukres.2018.06.003. Epub 2018 Jun 7.

PMID:
29914726
47.

[Functional role of DNMT3A mutation in acute myeloid leukemia].

Koya J, Kurokawa M.

Rinsho Ketsueki. 2018;59(5):602-610. doi: 10.11406/rinketsu.59.602. Review. Japanese.

PMID:
29877252
48.

Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg.

Oka T, Miyagaki T, Nakamura R, Funamizu K, Sugaya M, Ebisawa K, Koya J, Kurokawa M, Sato S.

Clin Exp Dermatol. 2018 Dec;43(8):930-933. doi: 10.1111/ced.13660. Epub 2018 May 31. No abstract available.

PMID:
29855057
49.

Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.

Furuya G, Abe H, Shinozaki-Ushiku A, Yamashita A, Ihara S, Hirata Y, Chiba A, Fujioka Y, Kurokawa M, Koike K, Fukayama M.

Pathol Res Pract. 2018 Jul;214(7):1051-1055. doi: 10.1016/j.prp.2018.05.022. Epub 2018 May 22.

PMID:
29843925
50.

Targeting chronic myeloid leukemia stem cells: can transcriptional program be a druggable target for cancers?

Masamoto Y, Kurokawa M.

Stem Cell Investig. 2018 Apr 24;5:10. doi: 10.21037/sci.2018.03.05. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center